Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02730728Completed
Randomised, open-label trial of ropivacaine in postoperative pain (3 arms), sponsored by University of Pennsylvania. Primary endpoint: Patients With Severe Pain at 48 Hours After Surgery. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02730728.